Jalaja Potluri, MD of AbbVie Inc. discusses the treatment trends for 2017 in acute myeloid leukemia at the 2017 ASCO Annual Meeting in Chicago, IL.
Jalaja Potluri, MD of AbbVie Inc. discusses the treatment trends for 2017 in acute myeloid leukemia at the 2017 ASCO Annual Meeting in Chicago, IL.